patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
crizotinib
Marketedupdated 2mo agoby $PFE PFIZER INC🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and non-small cell lung carcinoma and 14 investigational indications.
indications
investigational
NSCLC
targets
EML4-ALKNPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)ALK tyrosine kinase receptorHepatocyte growth factor receptorMacrophage-stimulating protein receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that